YP
IDXX icon

YANKCOM Partnership’s Idexx Laboratories IDXX Stock Holding History

YANKCOM Partnership’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$157K Sell
300
-65
-18% -$35.6K 0.05% 162
2026
Q2 		$192K Buy
365
+35
+11% +$19.6K 0.07% 150
2026
Q1 		$185K Sell
330
-1
-0.3% -$641 0.08% 142
2025
Q4 		$224K Buy
331
+66
+25% +$44.9K 0.1% 135
2025
Q3 		$169K Buy
+265
New +$161K 0.08% 146

Other funds holding IDXX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
AustralianSuper
AustralianSuper Melbourne, Australia $24.4B AUM 44.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

YANKCOM Partnership's IDXX Position: Q3 2026 in Review

YANKCOM Partnership reduced its Idexx Laboratories (IDXX) stake by 18% in Q3 2026, selling an estimated $35.6K and leaving 300 shares worth $157K. The position accounts for 0.05% of the portfolio, ranked #162.

YANKCOM Partnership first reported a position in IDXX in Q3 2025 and has held it in 5 quarters since. The position peaked at $224K in Q4 2025. 804 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • YANKCOM Partnership held 300 shares of Idexx Laboratories worth $157K as of Q3 2026.
  • YANKCOM Partnership sold 65 Idexx Laboratories shares in Q3 2026, an estimated $35.6K.
  • Idexx Laboratories made up 0.05% of YANKCOM Partnership's portfolio in Q3 2026, its #162 holding.
  • YANKCOM Partnership first reported a position in Idexx Laboratories in Q3 2025 and has held it in 5 quarters since.
  • YANKCOM Partnership's Idexx Laboratories position peaked at $224K in Q4 2025.
  • 804 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on YANKCOM Partnership's 13F filing for Q3 2026, filed 15 Oct 2026.